Latest in Cut Isn’t Lowering
Sort by
587 items
-
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday.Business - MarketWatch - November 12